1) Mocarski ES, Courcelle CT : Cytomegaloviruses and their replication. In : Fields Virology (ed by Knipe DM, et al), p 2629-2673, Lippincott Williams & Wilkins, Philadelphia, 2001.
2) Ho M : Cytomegalovirus : Biology and Infection, 2nd ed, Plenum, New York, 1991.
3) Pass RF : Cytomegalovirus. In : Fields Virology (ed by Knipe DM, et al), p 2675-2705, Lippincott Williams & Wilkins, Philadelphia, 2001.
4) Smith MG, Vellios F : Inclusion disease or generalized salivary gland virus infection. AMA Arch Pathol 50 : 862-884, 1950.
5) Rawlinson WD, et al : Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70 : 8833-8849, 1996.
9) Borysiewicz LK, et al : Lysis of human cytomegalovirus infected fibroblasts by natural killer cells : demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells. J Immunol 134 : 2695-2701, 1985.
11) Davignon JL, et al : Anti-human cytomegalovirus activity of cytokines produced by CD4 (+) T-cell clones specifically activated by IE1 peptides in vitro. J Virol 70 : 2162-2169, 1996.
12) Quinna GV, et al : Cytotoxic T cells in cytomegalovirus infection : HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 307 : 7-13, 1982.
13) Riddel SR, Greenburg PD : Tcell therapy of human CMV and EBV infection in immunocompromised hosts. Rev Med Virol 7 : 181-192, 1997.
15) Snydman DR, et al : Use of cytomegalovirus immune globlin to prevent cytomegalovirus diseases in renal transplant recipients. N Engl J Med 317 : 1049-1054, 1987.
17) Campbell A : Murine cytomegalovirus. In : Persistent Viral Infections (ed by Ahmed R, Chen SY), p447-466, John Willy & Sons Ltd, Baffins lane, 1999.
18) Selgrade MK, Osborn JE : Role of macrophages in resistance to murine cytomegalovirus. Infect Immun 10 : 1383-1390, 1974.
21) Mogensen SC : Role of macrophages on natural resistance to virus infections. Microbiol Rev 43 : 1-26, 1979.
22) Hanson LK, et al : Replication of murine cytomegalovirus in ditiferentiated macrophages as a determinant of viral pathogenesis. J Virol 73 : 5970-5980, 1999.
24) Soderberg-Naucler C, et al : Reactivation of latent cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91 : 119-126, 1997.
25) Bale JF, O'Neil ME : Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice. J Virol 63 : 2667-2673, 1989.
26) Collins TM, et al : Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J Virol 68 : 6305-6311, 1994.
27) Stoddart CA, et al : Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol 68 : 6243 -6253, 1994.
28) Koffron AJ, et al : Cellular localization of latent murine cytomegalovirus. J Virol 72 : 95-103, 1998.
32) MacDonald MR, et al : Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemoldne of novel structure. J Virol 73 : 3682-3691, 1999.
33) Fleming P, et al : The murine cytomegalovirus homolog, m131/129, is a determinant of viral pathogenicity. J Virol 73 : 6800-6809, 1999.
35) Noda S, et al : Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood, 2005. (http://www.bloodjournal.org/cgi/content/abstract/2005051833vl)
36) Mocarski ES, et al : Myeloid cell recruitment and function in pathogenesis and latency. In : Cytomegalovirus : Molecular Biology and Immunology (ed by Reddehase MJ), Caiser Academic Press, Norfolk, 2005.
37) Bukowski JF, et al : Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol 52 : 119-128, 1984.
39) Tay CH, Welsh RM : Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 71 : 267-275, 1997.
47) Lodoen M, et al : NKG2 D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible gene molecules. J Exp Med 197 : 1245-1253, 2003.
51) Orange JS, Biron CA : Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell response during murine cytomegalovirus infection. J Immunol 156 : 4746-4756, 1996.
52) Dalod M, et al : Dendritic cell responses to early murine cytomegalovirus infection : subset functional specialization and differential regulation by interferon α/β. J Exp Med 197 : 885-898, 2003.
58) Lucin P, et al : Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol 66 : 1977-1984, 1992.
62) MacComlac LP, Grundy JE : Human cytomegalovirus induces an Fcγ receptor (FcγR) in endothelial cells and fibroblasts that is distinct from the human cellular FcγRs. J Infect Dis 174 : 1151-1161, 1996.
63) Thale R, et al : Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol 68 : 7757-7765, 1994.
71) Polic B, et al : Hierarchical and redundunt lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188 : 1047-1054, 1998.
74) Tanaka K, et al : Role of the indigenous bacterial fiora in maintaining virus-specific CD8 T cells in the lungs of mice infected with murine cytomegalovirus (MCMV). (in preparation)